SOPHiA GENETICS
Healthcare Software · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
La Piece 12, Rolle, Vaud, 1180, Switzerl...Phone Number
+41 216941060Website
www.sophiagenetics.comRevenue
$86.2 MillionStock Symbol
SOPHIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
5
2
2
1
2
2
About SOPHiA GENETICS
SOPHiA GENETICS is a healthcare technology and data analytics company focused on advancing precision medicine through artificial intelligence and genomic data analysis. Founded by biologists with a mission to use data for positive global impact, the company develops innovative solutions that help clinicians, researchers, and biopharmaceutical organizations improve the diagnosis and treatment of complex diseases. Its core platform transforms large and complex datasets into actionable clinical insights, enabling more accurate understanding of cancer and rare genetic disorders.Explore more
SOPHiA GENETICS Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SOPHiA GENETICS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
SOPHiA GENETICS, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at SOPHiA GENETICS
Product Launch: Get notified when SOPHiA GENETICS launches new products
Check if SOPHiA GENETICS has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once SOPHiA GENETICS has new funding data
Click to see if SOPHiA GENETICS had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SOPHiA GENETICS recently announced quarterly report
Check out if SOPHiA GENETICS is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
SOPHiA GENETICS is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
SOPHiA GENETICS is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about SOPHiA GENETICS.
SOPHiA GENETICS financials insights
Gather financial insights about SOPHiA GENETICS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$3M
2014
Series B
$13.8M
2015
Series C
$15M
2017
Series D
$30M
2019
Series E
$77M
2020
Series F
$110M
2021
Share Placement
$234M
SOPHiA GENETICS Tech Stack
A closer look at the technologies used by SOPHiA GENETICS
See more technologies
Most Recent Scoops
Open Position
Pain Point
SOPHiA GENETICS is facing patent infringement claims filed by Guardant Health in the UK and at the Unified Patent Court in Paris, incurring approximately $1.1 million in net legal expenses during Q2 2026. On July 2, 2026, the UPC Court of Appeal rejected Guardant's appeal in full, while UK proceedings remain ongoing.
Intellectual Property, Lawsuits, Legal Affairs
Earnings
SOPHiA GENETICS has reported an operating loss of $20.1 million for Q2 2026, compared to $18.5 million in the prior year period, and an Adjusted EBITDA loss of $8.8 million, improving 27% year-over-year from a loss of $12.0 million in Q2 2025, with more than 60% of each incremental revenue dollar flowing to the bottom line.
Earnings, Finance
Partnership
SOPHiA GENETICS has partnered with the Children's Hospital of Philadelphia to develop a new liquid biopsy test optimized for pediatric cancers. The Children's Hospital of Philadelphia is noted as the first pediatric hospital in America and a global leader in pediatric oncology.
Partnership
Partnership
Partnership, Medical Research, Artificial Intelligence
SOPHiA GENETICS News & Media
SOPHiA GENETICS (SOPH) CTO sells 5000 shares in Rule 10b5-1 trading plan
CTO Abhimanyu Verma sold 5,000 SOPHiA GENETICS Ordinary Shares at $7.60 on Aug. 7, 2026, under a Rule 10b5-1(c) trading plan, and now directly holds 182,171 shares.SOPHiA GENETICS (SOPH) CTO trades 5000 shares under Rule 10b5-1 plan - Stock Titan
CTO Abhimanyu Verma sold 5,000 SOPHiA GENETICS shares at a weighted average of $6.9543 on 2026-08-04 under a Rule 10b5-1 plan, retaining 187,171 shares.SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript
SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call August 4, 2026 8:00 AM EDTCompany ParticipantsKellen Sanger - Head of Strategy and Investor RelationsRoss...SOPHiA GENETICS Reports Second Quarter 2026 Results
BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Revenue was $23.3 million, up...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SOPHiA GENETICS
Sign Up For FreeTo access detailed company insights
SOPHiA GENETICS is a healthcare technology and data analytics company focused on advancing precision medicine through artificial intelligence and genomic data analysis. Founded by biologists with a mission to use data for positive global impact, the company develops innovative solutions that help clinicians, researchers, and biopharmaceutical organ... Read More
